Administration
Administration
批准号:
9261462
负责人:
DAVID B. WEINER
金额:
$21.39万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-03-01 至 2020-02-29
关键词:
AdjuvantAnimalsAwardBiological AssayBiometryBiostatistics CoreClinicalClinical ResearchCore ProteinDNADNA VaccinesDataDevelopmentDevicesFeedbackFinancial SupportFundingGenesGoalsHIVHIV Vaccine Trials NetworkHIV vaccineHumanImmuneImmune responseLettersModalityNotificationOutcomePerformanceProcessProductivityProgram ReviewsPublicationsReagentRecombinant ProteinsReportingResearch PersonnelResourcesSamplingSeasonsStatistical Data InterpretationSuggestionSurfaceTimeUnited States National Institutes of HealthUpdateVaccinationVaccinesWorkbasedata sharingenv Gene Productsimprovedinnovationmeetingsmembernovelopen datapre-clinicalpreclinical developmentprogramssynthetic construct
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract Administrative Core - IPCAVD -– E-DNA + Env protein Vaccination for HIV
The goal of this program to produce an enhanced E/P delivered gene adjuvanted DNA vaccine (E-DNA) and
combine this with a highly novel polyvalent A, B, C, A/E recombinant protein boost (PPB) as a vaccine platform.
The EP focus of this application is to utilize novel surface delivery. By this combination we hypothesize that we
will generate an improved spectrum of T and B anti HIV immune responses compared to current HIV vaccine
modalities. This project builds on a major innovations and accomplishments by the members of this team that
have led to this proposal. The team has worked together productively for multiple years. Furthermore they have an
outstanding track record of productivity working with the HVTN. The inclusion of CHAVI investigators as part of
the preclinical development immune analysis is a major strength of the program. There are 3 highly interrelated,
translational focused, exceptionally novel projects which build on a strong track record of accomplishment
together that comprise this program. They are supported by a highly respected, important protein core as well as
seasoned administrative core.
The Administrative core (AC) is responsible for overall program performance, sample distribution, programmatic
oversight, HVTN and NIH Programmatic interactions and for recommending SAB members for program review.
The AC will arrange the annual SAB meeting and put in place a work plan to act on the SAB’s suggestions with
guidance of NIH program. The external SAB will be put in place upon notification of award of this program. The
administrative core will arrange team calls for open data discussion, and time line review, arrange monthly calls
with NIH program, arrange monthly calls to review progress with the PI and teams, arrange biannual data review
meetings and provide yearly written reports on progress for program feedback as well as facilitate publication of
findings and scientific meeting attendance for result reporting. The AC will also update the HVTN on a quarterly
basis relative to programmatic goals. We have an established HVTN development team to facilitate this process
and this will be expanded based on this application being funded (HVTN letter).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2023 International Society for Vaccines (ISV) Annual Congress, October 22-25, Lausanne, Switzerland
-
批准号:10754840
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2023
-
负责人:DAVID B. WEINER
-
依托单位:
Administrative Core
-
批准号:10589586
-
项目类别:
-
资助金额:$72.69万
-
财政年份:2022
-
负责人:DAVID B. WEINER
-
依托单位:
Administrative Core
-
批准号:10328139
-
项目类别:
-
资助金额:$27.52万
-
财政年份:2022
-
负责人:DAVID B. WEINER
-
依托单位:
Rapid, single-dose coronavirus vaccines via DNA-launched nanoparticles and genetic adjuvants for durable anti-coronavirus immunity
-
批准号:10328141
-
项目类别:
-
资助金额:$110.71万
-
财政年份:2022
-
负责人:DAVID B. WEINER
-
依托单位:
Synthetic DNA-launched and adjuvanted Env immunogens for HIV
-
批准号:10589585
-
项目类别:
-
资助金额:$449.79万
-
财政年份:2022
-
负责人:DAVID B. WEINER
-
依托单位:
Design and optimization of DL-NLTs and molecular adjuvants to increase potency and promote NAb formation in vivo
-
批准号:10589587
-
项目类别:
-
资助金额:$142.76万
-
财政年份:2022
-
负责人:DAVID B. WEINER
-
依托单位:
Novel DNA encoded monoclonal antibodies (DMAbs) for control of Antimicrobial Resistant (AMR) Pseudomonas aeruginosa infection
-
批准号:10459450
-
项目类别:
-
资助金额:$97.92万
-
财政年份:2019
-
负责人:DAVID B. WEINER
-
依托单位:
Novel DNA encoded monoclonal antibodies (DMAbs) for control of Antimicrobial Resistant (AMR) Pseudomonas aeruginosa infection
-
批准号:10004562
-
项目类别:
-
资助金额:$115.33万
-
财政年份:2019
-
负责人:DAVID B. WEINER
-
依托单位:
Novel DNA encoded monoclonal antibodies (DMAbs) for control of Antimicrobial Resistant (AMR) Pseudomonas aeruginosa infection
-
批准号:10228693
-
项目类别:
-
资助金额:$95.06万
-
财政年份:2019
-
负责人:DAVID B. WEINER
-
依托单位:
Multivalent DNA vaccine-mediated protection against Tuberculosis
-
批准号:10297846
-
项目类别:
-
资助金额:$86.53万
-
财政年份:2017
-
负责人:DAVID B. WEINER
-
依托单位:
Multivalent DNA vaccine-mediated protection against Tuberculosis
-
批准号:10054982
-
项目类别:
-
资助金额:$90.84万
-
财政年份:2017
-
负责人:DAVID B. WEINER
-
依托单位:
Synthetic DNA & Novel Env Vaccine for HIV
-
批准号:9024416
-
项目类别:
-
资助金额:$342.45万
-
财政年份:2015
-
负责人:DAVID B. WEINER
-
依托单位:
Synthetic DNA & Novel Env Vaccine for HIV
-
批准号:9261455
-
项目类别:
-
资助金额:$333.75万
-
财政年份:2015
-
负责人:DAVID B. WEINER
-
依托单位:
Development of a Universal Influenza Seasonal Vaccine
-
批准号:8721834
-
项目类别:
-
资助金额:$36.08万
-
财政年份:2010
-
负责人:DAVID B. WEINER
-
依托单位:
Development of a Universal Influenza Seasonal Vaccine
-
批准号:8317646
-
项目类别:
-
资助金额:$111.31万
-
财政年份:2010
-
负责人:DAVID B. WEINER
-
依托单位:
Development of a Universal Influenza Seasonal Vaccine
-
批准号:8525084
-
项目类别:
-
资助金额:$54.8万
-
财政年份:2010
-
负责人:DAVID B. WEINER
-
依托单位:
Development of a Universal Influenza Seasonal Vaccine
-
批准号:8143485
-
项目类别:
-
资助金额:$42.85万
-
财政年份:2010
-
负责人:DAVID B. WEINER
-
依托单位:
Development of a Universal Influenza Seasonal Vaccine
-
批准号:9352656
-
项目类别:
-
资助金额:$10.75万
-
财政年份:2010
-
负责人:DAVID B. WEINER
-
依托单位:
Development of a Universal Influenza Seasonal Vaccine
-
批准号:8017652
-
项目类别:
-
资助金额:$47.65万
-
财政年份:2010
-
负责人:DAVID B. WEINER
-
依托单位:
Training in Vaccine & Immune Therapeutics
-
批准号:7503022
-
项目类别:
-
资助金额:$19.41万
-
财政年份:2008
-
负责人:DAVID B. WEINER
-
依托单位:
海外基金